Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multi-arm Phase II Trial of Novel Agents for Treatment of High-risk COVID-19 Positive Patients

NCT04374019 is registered in ClinicalTrials.gov with Susanne Arnold as lead sponsor.

NCT NCT04374019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multi-arm Phase II Trial of Novel Agents for Treatment of High-risk COVID-19 Positive Patients
Lead sponsor
Susanne Arnold
Phase
Phase 2
Overall status
Terminated
Start date
May 1, 2020
Completion date
January 12, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, sars-cov2